21 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
and operations;
successfully managing relationships with the combined supplier base of Pyxis Oncology and Apexigen;
coordinating and integrating
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
Section 5.02(i)
Surviving Corporation
Section 1.01
Tax Return
Section 3.15(v)
Taxes
Section 3.15(v)
Top Supplier
Section 3.22(a)
Trade Laws
Section 9.03 … by such vendor and/or supplier during the applicable period) from which the Company or any Company Subsidiary ordered raw materials, components
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
5.02(i)
Surviving Corporation
Section 1.01
Tax Return
Section 3.15(v)
Taxes
Section 3.15(v)
Top Supplier
Section 3.22(a)
Trade Laws
Section 9.03 … by such vendor and/or supplier during the applicable period) from which the Company or any Company Subsidiary ordered raw materials, components, supplies
S-4
kvf20l6jxn2zca g0
8 Apr 22
Registration of securities issued in business combination transactions
6:37pm
10-K
ycxpmzgvss
7 Apr 22
Annual report
5:13pm
DEF 14A
6qpso75jkbnlt42
28 Mar 22
Definitive proxy
5:30pm
PRE 14A
f58paedyn1z9 j6xl
18 Mar 22
Preliminary proxy
5:21pm
425
EX-2.1
yle3h4k
18 Mar 22
Business combination disclosure
7:13am
8-K
EX-2.1
sdrklf8n aqrbql
18 Mar 22
Apexigen and Brookline Capital Acquisition Corp. Announce Business
7:01am
8-K
EX-1.1
scgc7y 0b
2 Feb 21
Brookline Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
5:21pm
424B4
wl8x737s
29 Jan 21
Prospectus supplement with pricing info
10:01am
S-1/A
EX-14
fr1z1n n2
24 Aug 20
IPO registration (amended)
12:00am
S-1/A
EX-1.1
svi16a
24 Aug 20
IPO registration (amended)
12:00am
S-1
shwblrnmnbso8996
14 Aug 20
IPO registration
3:23pm